Changsong S. Qi

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Guanylyl Cyclase 2C-Targeted Chimeric Antigen Receptor T-Cell Therapy in Patients With Metastatic Colorectal Cancer.

Guanylyl Cyclase 2C-Targeted Chimeric Antigen Receptor T-Cell Therapy in Patients With Metastatic Colorectal Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 04, 2026

Construction of a 89Zr-Labeled Specific Antibody Fragment for the Noninvasive Detection of Mesothelin-Overexpressing Tumors.

Construction of a 89Zr-Labeled Specific Antibody Fragment for the Noninvasive Detection of Mesothelin-Overexpressing Tumors.

Journal: Molecular pharmaceutics

Published: May 12, 2026

Long-term control of peritoneal metastases following claudin 18.2-targeted CAR T-Cell therapy in advanced gastric cancer.

Long-term control of peritoneal metastases following claudin 18.2-targeted CAR T-Cell therapy in advanced gastric cancer.

Journal: Journal of hematology & oncology

Published: April 19, 2026

Tumor empowered binary macrophages regulate T cell interferon signaling to mediate immunotherapy resistance in gastric cancer.

Tumor empowered binary macrophages regulate T cell interferon signaling to mediate immunotherapy resistance in gastric cancer.

Journal: Science bulletin

Published: January 19, 2026

Larotrectinib in TRK fusion differentiated thyroid carcinoma: updated trial data.

Larotrectinib in TRK fusion differentiated thyroid carcinoma: updated trial data.

Journal: Endocrine-related cancer

Published: December 17, 2025

Allogeneic B7-H3-Targeted CAR Vδ1T-cell Therapy in Advanced Solid Tumors: A Phase I Study.

Allogeneic B7-H3-Targeted CAR Vδ1T-cell Therapy in Advanced Solid Tumors: A Phase I Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 03, 2025

Efficacy of chemotherapy combined with targeted therapy and immunotherapy versus chemotherapy alone in advanced pancreatic cancer:a retrospective cohort study

Efficacy of chemotherapy combined with targeted therapy and immunotherapy versus chemotherapy alone in advanced pancreatic cancer:a retrospective cohort study

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: November 26, 2025

Rethinking CLDN18.2 expression in gastric cancer therapy - Authors' reply.

Rethinking CLDN18.2 expression in gastric cancer therapy - Authors' reply.

Journal: Lancet (London, England)

Published: November 10, 2025

Optimizing CAR T cell therapy for solid tumours: a clinical perspective.

Optimizing CAR T cell therapy for solid tumours: a clinical perspective.

Journal: Nature reviews. Clinical oncology

Published: September 03, 2025

TPM3-NTRK1 fusion confers resistance to osimertinib in lung adenocarcinoma: a model in a continuous cell line.

TPM3-NTRK1 fusion confers resistance to osimertinib in lung adenocarcinoma: a model in a continuous cell line.

Journal: Human cell

Published: August 18, 2025

Impact of concomitant medications on efficacy of CLDN18.2-specific CAR-T cell therapy in advanced gastric cancer.

Impact of concomitant medications on efficacy of CLDN18.2-specific CAR-T cell therapy in advanced gastric cancer.

Journal: British journal of cancer

Published: May 29, 2025

Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial.

Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial.

Journal: British journal of cancer

Published: April 15, 2025

Showing 1-12 of 80

Last Updated: 09/26/2026